
Zota Health Care (ZOTA) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.0B
Gross Profit
584.5M
56.43%
Operating Income
-107.2M
-10.35%
Net Income
-137.8M
-13.30%
EPS (Diluted)
₹-4.92
Balance Sheet Metrics
Total Assets
4.4B
Total Liabilities
2.1B
Shareholders Equity
2.3B
Debt to Equity
0.93
Cash Flow Metrics
Operating Cash Flow
-8.6M
Free Cash Flow
41.9M
Revenue & Profitability Trend
Zota Health Care Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 2.9B | 1.8B | 1.4B | 1.3B | 1.1B |
Cost of Goods Sold | 1.4B | 1.0B | 848.3M | 893.1M | 757.5M |
Gross Profit | 1.6B | 803.4M | 551.3M | 418.9M | 310.4M |
Gross Margin % | 53.1% | 44.5% | 39.4% | 31.9% | 29.1% |
Operating Expenses | |||||
Research & Development | - | - | - | - | 0 |
Selling, General & Administrative | - | 412.8M | 340.9M | 159.6M | 201.8M |
Other Operating Expenses | 753.4M | 5.5M | 3.3M | 2.0M | 1.6M |
Total Operating Expenses | 753.4M | 418.3M | 344.2M | 161.6M | 203.4M |
Operating Income | -489.3M | -126.1M | -38.3M | 112.0M | -21.5M |
Operating Margin % | -16.7% | -7.0% | -2.7% | 8.5% | -2.0% |
Non-Operating Items | |||||
Interest Income | - | 9.5M | 8.8M | 13.2M | 7.2M |
Interest Expense | 107.8M | 42.0M | 24.9M | 2.6M | 504.0K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -576.4M | -161.6M | -46.9M | 124.3M | -3.7M |
Income Tax | -9.1M | -18.2M | 10.8M | 35.3M | -1.6M |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 28.4% | 0.0% |
Net Income | -567.4M | -143.5M | -57.7M | 89.1M | -2.1M |
Net Margin % | -19.4% | -7.9% | -4.1% | 6.8% | -0.2% |
Key Metrics | |||||
EBITDA | -36.6M | 82.1M | 92.1M | 163.6M | 18.2M |
EPS (Basic) | ₹-20.68 | ₹-5.59 | ₹-2.29 | ₹3.58 | ₹-0.09 |
EPS (Diluted) | ₹-20.68 | ₹-5.59 | ₹-2.29 | ₹3.58 | ₹-0.09 |
Basic Shares Outstanding | 27271954 | 25644606 | 25160327 | 24884163 | 24560327 |
Diluted Shares Outstanding | 27271954 | 25644606 | 25160327 | 24884163 | 24560327 |
Income Statement Trend
Zota Health Care Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 21.3M | 6.8M | 919.0K | 383.0K | 152.0K |
Short-term Investments | 14.9M | 3.3M | 10.2M | 22.6M | 13.3M |
Accounts Receivable | 405.0M | 272.4M | 278.3M | 363.7M | 287.7M |
Inventory | 1.1B | 537.7M | 417.9M | 289.5M | 281.8M |
Other Current Assets | 173.7M | 1.0K | 1.0K | -1.0K | -1.0K |
Total Current Assets | 1.8B | 1.1B | 841.7M | 769.0M | 612.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 1.8B | 3.8M | 3.8M | 3.8M | 3.8M |
Goodwill | 49.2M | 40.7M | 42.9M | 54.7M | 64.7M |
Intangible Assets | 49.2M | 40.7M | 42.9M | 54.7M | 64.7M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | -1.0K | -1.0K | -2.0K | -2.0K |
Total Non-Current Assets | 2.5B | 1.2B | 739.4M | 621.9M | 242.6M |
Total Assets | 4.4B | 2.3B | 1.6B | 1.4B | 854.7M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 424.0M | 336.1M | 264.6M | 187.0M | 156.0M |
Short-term Debt | 320.5M | 321.2M | 88.6M | 24.4M | 0 |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 100.8M | 8.8M | 5.3M | 4.1M | 1.1M |
Total Current Liabilities | 1.0B | 736.8M | 405.2M | 359.6M | 182.3M |
Non-Current Liabilities | |||||
Long-term Debt | 1.1B | 631.6M | 362.6M | 124.6M | 0 |
Deferred Tax Liabilities | - | - | - | - | 67.0K |
Other Non-Current Liabilities | 7.0K | 1.0K | - | 2.0K | 1.0K |
Total Non-Current Liabilities | 1.1B | 646.7M | 372.4M | 135.1M | 9.4M |
Total Liabilities | 2.1B | 1.4B | 777.6M | 494.7M | 191.7M |
Equity | |||||
Common Stock | 286.4M | 258.5M | 251.6M | 251.6M | 245.6M |
Retained Earnings | - | 658.8M | 457.5M | 187.1M | 121.8M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 2.3B | 899.8M | 803.6M | 896.3M | 663.0M |
Key Metrics | |||||
Total Debt | 1.4B | 952.8M | 451.2M | 149.0M | 0 |
Working Capital | 835.5M | 379.3M | 436.5M | 409.4M | 429.8M |
Balance Sheet Composition
Zota Health Care Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -576.4M | -161.6M | -46.9M | 124.3M | -3.7M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 5.9M | 3.5M | 0 | - | - |
Working Capital Changes | -511.0M | -502.1M | -298.0M | -30.9M | -26.6M |
Operating Cash Flow | -1.0B | -627.7M | -333.3M | 83.3M | -37.2M |
Investing Activities | |||||
Capital Expenditures | -459.7M | -166.1M | -113.6M | -32.5M | -8.4M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | -248.4M | - |
Investment Sales | - | - | - | - | 40.4M |
Investing Cash Flow | -459.7M | -166.1M | -113.6M | -280.9M | 31.9M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -27.4M | -25.8M | -37.7M | -25.2M | -24.6M |
Debt Issuance | - | - | - | - | - |
Debt Repayment | -140.7M | - | -17.2M | -11.4M | -498.0K |
Financing Cash Flow | 1.6B | 381.8M | -54.9M | 150.4M | -24.1M |
Free Cash Flow | -959.4M | -226.9M | -145.1M | 100.8M | -28.2M |
Net Change in Cash | 113.4M | -412.0M | -501.8M | -47.1M | -29.3M |
Cash Flow Trend
Zota Health Care Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-63.68
Price to Book
37.52
Price to Sales
14.14
PEG Ratio
-25.47
Profitability Ratios
Profit Margin
-20.55%
Operating Margin
-10.35%
Return on Equity
-38.38%
Return on Assets
-12.84%
Financial Health
Current Ratio
1.83
Debt to Equity
0.61
Beta
0.45
Per Share Data
EPS (TTM)
₹-20.79
Book Value per Share
₹35.76
Revenue per Share
₹91.99
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
zota | 34.7B | -63.68 | 37.52 | -38.38% | -20.55% | 0.61 |
Biocon | 478.0B | 111.24 | 1.98 | 3.66% | 2.44% | 66.26 |
OneSource Specialty | 208.0B | -1,112.76 | 3.53 | -0.31% | -0.85% | 16.03 |
Dishman Carbogen | 41.9B | 40.09 | 0.72 | 0.06% | 3.60% | 40.97 |
Panacea Biotec | 25.1B | 91.93 | 3.00 | -1.01% | 1.88% | 2.67 |
3B Blackbio | 12.3B | 25.02 | 4.79 | 17.58% | 49.51% | 0.11 |
Financial data is updated regularly. All figures are in the company's reporting currency.